Segment Information and Concentration (Tables)

3 Months Ended

6 Months Ended

Mar. 31, 2023

Dec. 31, 2022

Segment Information and Concentration

Schedule Of Segment Information

Three Months Ended March 31, 2023:	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Revenues	$	2,582,200	$	223,200		$	-		$	2,805,400
Foreign Sales		856,600		95,900						952,500
Income (Loss) From Operations		266,200		(2,072,500	)		(661,300	)		(2,467,600	)
Assets		7,810,900		5,174,100			3,379,000			16,364,000
Long-Lived Asset Expenditures		8,200		37,600			-			45,800
Depreciation and Amortization		23,300		164,600			-			187,900
Three Months Ended March 31, 2022:	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Revenues	$	2,434,600	$	430,300		$	-		$	2,864,900
Foreign Sales		783,600		269,700						1,053,300
Income (Loss) From Operations		247,300		(1,651,700	)		(337,900	)		(1,742,300	)
Assets		10,231,100		10,024,261			10,271,439			30,526,800
Long-Lived Asset Expenditures		16,500		158,000			-			174,500
Depreciation and Amortization		24,600		229,900			-			254,500

Six Months Ended December 31, 2022	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Revenues	$	4,608,900	$	628,900		$	-		$	5,237,800
Foreign Sales		1,322,500		478,200			-			1,800,700
Income (Loss) From Operations		203,500		(3,483,200	)		(902,300	)		(4,137,000	)
Assets		8,622,500		5,174,600			4,272,100			18,069,200
Long-Lived Asset Expenditures		34,300		220,200			-			254,500
Depreciation and Amortization		50,100		330,700			-			380,800

Six Months Ended December 31, 2021 (Unaudited)	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Revenues	$	5,031,100	$	727,500		$	-		$	5,758,600
Foreign Sales		2,031,100		521,500			-			2,552,600
Income (Loss) From Operations		851,700		(3,712,700	)		(508,200	)		(3,369,200	)
Assets		9,715,400		10,064,500			9,072,600			28,852,500
Long-Lived Asset Expenditures		66,600		163,300			-			229,900
Depreciation and Amortization		46,600		280,700			-			327,300

Year Ended June 30, 2022 (As Restated)	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Revenues	$	9,981,100	$	1,419,400		$	-		$	11,400,500
Foreign Sales		3,702,400		1,101,400			-			4,803,800
Income (Loss) From Operations		1,475,800		(11,369,500	)		(1,650,400	)		(11,544,100	)
Assets		9,538,600		5,077,500			6,391,800			21,007,900
Long-Lived Asset Expenditures		92,500		732,100			-			824,600
Depreciation and Amortization		96,300		591,900			-			688,200

Year Ended June 30, 2021	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Revenues	$	9,043,600	$	731,600		$	-		$	9,775,200
Foreign Sales		3,483,700		684,600			-			4,168,300
Income (Loss) From Operations		1,461,300		(4,828,600	)		(1,341,400	)		(4,708,700	)
Assets		14,783,000		8,735,100			5,488,300			29,006,400
Long-Lived Asset Expenditures		60,500		196,900			-			257,400
Depreciation and Amortization		103,100		148,400			-			251,500

Schedule Of Reconciliation Of The Company's consolidated Segment Incomed Loss

For the three months ended March 31, 2023	Benchtop Laboratory Equipment			Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	266,200		$	(2,072,500	)	$	(661,300	)	$	(2,467,600	)
Other income (expense), net		(1,800	)		11,000			77,100			86,300
Interest income		-			-			9,400			9,400
Total other (expense) income, net		(1,800	)		11,000			86,500			95,700
Income (Loss) from operations before discontinued operations and income taxes	$	264,400		$	(2,061,500	)	$	(574,800	)	$	(2,371,900	)
For the three months ended March 31, 2022	Benchtop Laboratory Equipment			Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	247,300		$	(1,651,700	)	$	(337,900	)	$	(1,742,300	)
Other (expense) income, net		1,300			(18,400	)		(85,600	)		(102,700	)
Interest income		-			-			400			400
Total other (expense) income, net		1,300			(18,400	)		(85,200	)		(102,300	)
Income (Loss) from operations before discontinued operations and income taxes	$	248,600		$	(1,670,100	)	$	(423,100	)	$	(1,844,600	)

Geographical Information

	Six Months Ended
	December 31, 2022				December 31, 2021 (unaudited)
	Revenue (a)		Long-Lived Assets		Revenue (a)		Long-Lived Assets
United States	$	3,437,000	$	1,710,000	$	3,206,000	$	5,181,300
All Other Foreign Countries		1,454,700		-		2,276,100		-
Germany		346,100		885,000		276,500		138,000
Total	$	5,237,800	$	2,595,000	$	5,758,600	$	5,319,300

Income (loss) from operations before discontinued operations and income taxes

Six Months ended December 31, 2022	Benchtop Laboratory Equipment			Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	203,500		$	(3,438,200	)	$	(902,300	)	$	(4,137,000	)
Other (expense) income, net		(28,200	)		3,600			88,500			63,900
Income (Loss) from operations before discontinued operations and income taxes	$	175,300		$	(3,434,600	)	$	(813,800	)	$	(4,073,100	)

Six Months ended December 31, 2021 (unaudited)	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	851,700	$	(3,712,700	)	$	(508,200	)	$	(3,369,200	)
Other (expense) income, net		415,500		52,500			47,600			515,600
Income (Loss) from operations before discontinued operations and income taxes	$	1,267,200	$	(3,660,200	)	$	(460,600	)	$	(2,853,600	)

Year ended June 30, 2022 (As Restated)	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	1,475,800	$	(11,369,500	)	$	(1,650,400	)	$	(11,544,100	)
Other (expense) income, net		194,000		(3,100	)		71,500			262,400
Income (Loss) from operations before discontinued operations and income taxes	$	1,669,800	$	(11,372,600	)	$	(1,578,900	)	$	(11,281,700	)

Year ended June 30, 2021	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	1,461,300	$	(4,828,600	)	$	(1,341,500	)	$	(4,708,800	)
Other (expense) income, net		571,000		600			82,200			653,800
Income (Loss) from operations before discontinued operations and income taxes	$	2,032,300	$	(4,828,000	)	$	(1,259,300	)	$	(4,055,000	)